The management of organ transplantation ward during the COVID-19 epidemic: a single-institution experience

doi:10.3877/cma.j.issn.1674-3903.2020.02.004

Abstract

Abstract:

Corona virus disease 2019 (COVID-19) spreaded widely and infected a large number of persons when it occurred on December 2019. It seriously impacted our society and meanwhile brought great challenge to organ transplant ward management of hospital. Liver transplantation recipients may be more susceptible to COVID-19 than the general population because of hypoimmunity. So the management of liver transplant ward had its particularity. Medical staff in the department of liver transplantation, the Affiliated Hospital of Qingdao University carefully learned the COVID-19 related control, diagnosis and treatment scheme and guideline which released by National Health Commission of the People′s Republic of China. So as to strengthen the self-protection of medical staff, make inpatient management procedures adapting COVID-19 epidemic status, improve the knowledge of the COVID-19 for patients and their family members, and eventually establish an effective management program for liver transplant ward. Through the fruitful ward management in the special COVID-19 situation, we hope to apply scientific treatment for every liver transplant patient and avoided the COVID-19 infecting effectively at the same time.

Key words: Corona virus disease 2019, Liver transplantation, Ward management

Xin Wang, Wenyan Zhu, Chuanshen Xu, Feng Wang, Xiaoyue Fu, Yunjin Zang. The management of organ transplantation ward during the COVID-19 epidemic: a single-institution experience[J]. Chinese Journal of Transplantation(Electronic Edition), 2020, 14(02): 79-82.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhyzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3903.2020.02.004

https://zhyzzz.cma-cmc.com.cn/EN/Y2020/V14/I02/79

Figures/Tables 2

References 7

[4]	Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223): 507-513.
[5]	中华医学会器官移植学分会. 新型冠状病毒肺炎疫情期间全国器官捐献与移植工作的指导原则[J]. 器官移植，2020, 11(2): 179-184.
[6]	魏秋华，任哲. 2019新型冠状病毒感染的肺炎疫源地消毒措施[J]. 中华消毒学杂志，2020, 37(1): 59-62.
[7]	张文福，何俊美，帖金凤，等. 冠状病毒的抵抗力与消毒[J]. 中国消毒学杂志，2020, 37(1): 1-5.
[1]	国家卫生健康委员会. 医疗机构内新型冠状病毒感染预防与控制技术指南(第一版) [EB/OL]．(2020-01-23)[2020-02-19]． URL
[2]	国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第六版)[EB/OL]．(2020-02-19)[2020-02-19]． URL
[3]	国家卫生健康委员会. 新型冠状病毒肺炎防控方案(第五版)[EB/OL]. (2020-02-20)[2020-02-21]． URL

尊敬的各位病友：
您好！
为积极应对新型冠状病毒肺炎疫情，落实各项防控措施，防止疫情扩散，保障您和他人安全，请您配合工作人员进行信息核查并签字确认，否则将承担相应法律责任！
姓名：	身份证号：	住院号：	床号：
现住址：	?	?	?
1.目前体温(护士测量)：
2. 2周内是否有青岛市六区以外地区旅行史或居住史：□否□是
3. 2周内是否去过新型冠状病毒肺炎病例报告社区或居住史：□否□是
4. 2周内是否乘坐过新型冠状病毒肺炎病例报告公共交通工具：□否□是
5. 2周内是否接触过来自新型冠状病毒肺炎病例报告地区的人员：□否□是
6. 2周内是否接触过新型冠状病毒肺炎疑似或确诊患者：□否□是
7. 2周内是否有发热情况(≥37.3℃): □否□是
8. 2周内是否有乏力、腹泻、干咳、胸闷和气促等症状：□否□是(请具体填写)
9. 2周内是否到过其他医疗机构就诊：□否□是其他医疗机构名称：
10. 2周内是否有日韩旅居史或接触过来自日韩的人员：□否□是
请在下面空白处填写以上情况是否属实并签字。
核查者签字：
患者/家属签字：
?	?	?	日期：
?	?	?	青岛大学附属医院肝脏移植科

尊敬的各位病友：
您好！
为积极应对新型冠状病毒肺炎疫情，落实各项防控措施，防止疫情扩散，保障您和他人安全，请您配合工作人员进行信息核查并签字确认，否则将承担相应法律责任！
姓名：	身份证号：	住院号：	床号：
现住址：	?	?	?
1.目前体温(护士测量)：
2. 2周内是否有青岛市六区以外地区旅行史或居住史：□否□是
3. 2周内是否去过新型冠状病毒肺炎病例报告社区或居住史：□否□是
4. 2周内是否乘坐过新型冠状病毒肺炎病例报告公共交通工具：□否□是
5. 2周内是否接触过来自新型冠状病毒肺炎病例报告地区的人员：□否□是
6. 2周内是否接触过新型冠状病毒肺炎疑似或确诊患者：□否□是
7. 2周内是否有发热情况(≥37.3℃): □否□是
8. 2周内是否有乏力、腹泻、干咳、胸闷和气促等症状：□否□是(请具体填写)
9. 2周内是否到过其他医疗机构就诊：□否□是其他医疗机构名称：
10. 2周内是否有日韩旅居史或接触过来自日韩的人员：□否□是
请在下面空白处填写以上情况是否属实并签字。
核查者签字：
患者/家属签字：
?	?	?	日期：
?	?	?	青岛大学附属医院肝脏移植科

[1]	Anqi Li, Yilin Xu, Tianxin Xiang. Progress on diagnosis and treatment of post corona virus disease 2019 pulmonary fibrosis [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(05): 294-298.
[2]	Mingchao Zhu, Ya Zhu, Feibo Guo, Yine Huang. Influence on blood routine parameters of severe acute respiratory syndrome coronavirus 2 infection induced cold condensation aggregation [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(04): 244-251.
[3]	Kunhe Li, Mengjia Kou, Liting Kuang. Risk factors and prediction model of reintubation after liver transplantation [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(05): 366-371.
[4]	Branch of Organ Transplant of Chinese Medical Association, Branch of Organ Transplant Physicians of Chinese Medical Doctor Association, Shanghai Pharmaceutical Profession Association. Expert Consensus on the Use of Mycophenolic Acid in Chinese Liver and Kidney Transplant Recipients (2023 edition) [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 257-272.
[5]	Wenqing Lu, Xinyi Chen, Xuefei Ren. Investigation on the quality of life after liver transplantation in children with genetic metabolic diseases [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 287-292.
[6]	Tieyan Fan, Jun Li, Hong Chen. Diagnosis and treatment experience of new onset viral hepatitis E after liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 293-296.
[7]	Shuo Chen, Feng Chen, Fei Cheng, Jie Xiang. Pancreas infarction after liver transplantation for glycogen storage disease type Ⅰ complicated with pancreatitis: a case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 300-302.
[8]	Penghao Tang, Wu Zhang. Progress in mechanism research about intestinal microecology with perioperative complications of liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(05): 303-307.
[9]	Lina Zhu, Zizhen Yang, Di Zhang, Yong Zhang, Jinzhen Cai, Jianhong Wang. The application value of contrast-enhanced ultrasound in the diagnosis of hepatic artery complications after liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(04): 240-245.
[10]	Committee of Health Management for Organ Transplant Recipient, China Organ Transplantation Development Foundation, Branch of Organ Transplant Physicians of Chinese Medical Doctor Association, Branch of Organ Transplant of Chinese Medical Association, National Center for Healthcare Quality Management in Liver Transplant. Chinese expert consensus on clinical application of inhibitors of mammalian target of rapamycin in liver transplant recipients (2023 edition) [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(04): 193-204.
[11]	Qing Yan, Ying Liu, Feiwen Deng, Huanwei Chen. Effect of microvascular invasion on survival and prognosis of liver transplantation recipients with liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 624-629.
[12]	Mei Liao, Hongjun Zhang, Jieyang Jin, Yan Lyu, Jie Ren. Diagnostic value of bedside contrast-enhanced ultrasound for early hepatic artery thrombosis after liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 630-634.
[13]	Binglin Li, Shaocheng Lyu, Fei Pan, Tao Jiang, Hua Fan, Jiantao Kou, Qiang He, Ren Lang. Correlation analysis between pathogenic bacteria of donor liver perfusion fluid and early infection after liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 656-660.
[14]	Lei Lyu, Xiao Feng, Kaiming He, Kaining Zeng, Qing Yang, Haijin Lyu, Huimin Yi, Shuhong Yi, Yang Yang, Binsheng Fu. Value of revised King's score in evaluation of live transplantation timing for children with acute liver failure due to Wilson's disease and literature review [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 661-668.
[15]	Menglong Wang. Significance of biological characteristics in liver transplantation for HCC [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 490-494.

Please choose a citation manager

Content to export